Ross Clark

Over the past few weeks the government’s scientific advisers have indicated that the only real way out of the coronavirus crisis is a vaccine – until then a high degree of social distancing will have to remain. Given that no-one expects a vaccine to be ready for deployment for another year at the very earliest, this would have very serious implications for the economy, and for society at large. But there is another possible route out of social distancing – not so good, but possibly available a lot more quickly. This is for an effective therapeutic drug to emerge. It would not stop anyone contracting the virus but could improve the prospects for those who do catch it.

Six weeks ago Britain stood as a bit of an outlier among western countries in that our government seemed set to manage, rather than suppress, coronavirus. It rejected the idea that it was pursuing ‘herd immunity,’ but seemed to do just that. Now we stand out for a different reason: we are the only country which appears to be committing itself to remain in lockdown, or close approximation thereof, until a vaccine arrives. In much of Europe, lockdown restrictions are tentatively being relaxed as infection rates and death rates fall. Here, ministers tell us it is far too early for that sort of thing – we will need restrictions on our lives, in one form or another, until we have a vaccine available. Is that a plausible strategy?

Finally, the government is to start antibody tests to see how prevalent infection with the SARS-CoV-2 virus – which causes Covid-19 – is among the general population. Over the next few days, testing kits are being sent to 20,000 randomly-selected households. The results will be crucial because it will inform us how effective lockdown has been – and whether there is any point in continuing with that policy. If, say, five per cent showed signs of having had the virus it would mean that the epidemic potentially had a long way yet to run. If 50 per cent have been infected with the virus it would mean that lockdown has failed and was pointless in any case – we would already be on the verge of herd immunity. So what will be the result?

The science of epidemiology relies a lot on modelling because, for obvious reasons, controlled experimentation would be unethical. But in the case of Covid-19 we do have something approaching a real-life experiment – in that Sweden has declined to follow other European countries into lockdown. Instead, it has followed a policy which might be summed up as social distancing-lite. Gatherings of more than 50 people have been outlawed, closing theatres and putting an end to sports events. But children up to the age of 16 are still attending school, shops and restaurants are still open – albeit with rules preventing people standing up at the bar – and no police officer is to blow a whistle at you for sitting on a park bench.

Another day, and yet more evidence has appeared that could indicate the number of people who have been infected with SARS-CoV-2, the virus which causes Covid-19, might be vastly higher than official figures suggest. This time a Californian study suggests the figure in one county could be more than 50 times the number who knew they had had the virus. A team from Stanford university and other US universities recruited volunteers in Santa Clara County via Facebook adverts and produced a sample of 3000 representatives of the county as a whole. They were then invited for blood tests to detect the presence of antibodies to the virus. The result was positive in 1.5 per cent of cases. Adjusting for age, gender and ethnicity the results suggest that 2.

Coronavirus, we have been warned many times, has brought scammers out in force. But lobbyists are not far behind. Their activities may not be illegal, but they are pretty disgraceful nonetheless. Hardly had the coronavirus outbreak begun in January than my email inbox began to fill up with press releases claiming that the contagion was being spread by banknotes and coins — coming, er, from businesses with a vested interest in cashless payments. In Britain, the payments industry seized the moment to lobby the government — successfully — for the limit on payments via contactless cards to be raised from £30 to £45. The new limit duly came into effect on April 1.

It just keeps on getting worse. Like the death toll from Covid-19 itself, forecasts for the economy in the wake of the crisis keep on creeping upwards. Today, the Office for Budget Responsibility (OBR) forecasts that UK GDP could contract by 35 per cent by June if the lockdown continues until then, before 'bouncing back quickly'. Unemployment could rise, it says, by two million, with the unemployment rate climbing to 10 per cent. That is quite a shock given that on the eve of this crisis we were celebrating the highest employment ever and the lowest unemployment in 45 years. The 35 per cent contraction is making all the headlines today – as well it might.

This morning we have some data giving a little more insight into the great unknown of the coronavirus pandemic: just how widely among the population has SARS-CoV-2 – the virus which causes Covid-19 – spread among the general population. A team at the University of Bonn has tested a randomised sample of 1,000 residents of the town of Gangelt in the north-west of the country, one of the epicentres of the outbreak in Germany. The study found that two per cent of the population currently had the virus and that 14 per cent were carrying antibodies suggesting that they had already been infected – whether or not they experienced any symptoms.